0001104659-19-032916.txt : 20190530
0001104659-19-032916.hdr.sgml : 20190530
20190530212625
ACCESSION NUMBER: 0001104659-19-032916
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190528
FILED AS OF DATE: 20190530
DATE AS OF CHANGE: 20190530
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Anstey Michael
CENTRAL INDEX KEY: 0001776856
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38916
FILM NUMBER: 19868373
MAIL ADDRESS:
STREET 1: C/O BICYCLE THERAPEUTICS LIMITED
STREET 2: B900 BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3AT
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BICYCLE THERAPEUTICS plc
CENTRAL INDEX KEY: 0001761612
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: B900 BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3AT
BUSINESS PHONE: 011441223261503
MAIL ADDRESS:
STREET 1: B900 BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3AT
FORMER COMPANY:
FORMER CONFORMED NAME: BICYCLE THERAPEUTICS Ltd
DATE OF NAME CHANGE: 20181212
4
1
a4.xml
4
X0306
4
2019-05-28
0
0001761612
BICYCLE THERAPEUTICS plc
BCYC
0001776856
Anstey Michael
C/O BICYCLE THERAPEUTICS PLC
B900, BABRAHAM RESEARCH CAMPUS
CAMBRIDGE
X0
CB22 3AT
UNITED KINGDOM
1
0
0
0
Ordinary Shares
2019-05-28
4
C
0
1081823
A
1081823
I
By Cambridge Innovation Capital (Jersey) Limited
Ordinary Shares
2019-05-28
4
X
0
125587
A
1207410
I
By Cambridge Innovation Capital (Jersey) Limited
Ordinary Shares
2019-05-28
4
C
0
229741
A
1437151
I
By Cambridge Innovation Capital (Jersey) Limited
Ordinary Shares
2019-05-28
4
P
0
314286
14
A
1751437
I
By Cambridge Innovation Capital (Jersey) Limited
Series B1 Preferred Shares
2019-05-28
4
C
0
1081823
A
Ordinary Shares
1081823
0
I
By Cambridge Innovation Capital (Jersey) Limited
Series B1 Preferred Shares Warrants
2019-05-28
4
X
0
125587
A
Ordinary Shares
125587
0
I
By Cambridge Innovation Capital (Jersey) Limited
Series B2 Preferred Shares
2019-05-28
4
C
0
229741
A
Ordinary Shares
229741
0
I
By Cambridge Innovation Capital (Jersey) Limited
Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date.
The shares are held by Cambridge Innovation Capital (Jersey) Limited. The Reporting Person is a member of our Board of Directors and an investment director at Cambridge Innovation Capital plc.
Upon conversion of all of the Series B1 Preferred Shares into Ordinary Shares in connection with the Issuer's initial public offering, the Warrants became exercisable for Ordinary Shares. The Warrants had an exercise price of a nominal value per share and were exercised immediately prior to completion of the Issuer's initial public offering.
/s/ Lee Kalowski, as Attorney-in-Fact
2019-05-30